ASPE

12.4200.24%
AS

Andrew Spaventa

Independent Director

Mr. Andrew Spaventa, also known as Drew, is Independent Director of Aspen Neuroscience, Inc. from June 2020. Mr. Spaventa joined the Aspen Neuroscience, Inc. in June 2020. Mr. Spaventaserves as Special advisor to the CEO at Singular Genomics Systems, Inc. since February 21, 2025. He Co-Founded Singular Genomics Systems, Inc. in 2016 and has been its Director since 2016. Mr. Spaventa served as the Chairman and Chief Executive Officer of Singular Genomics Systems, Inc. until February 21, 2025 and had been its President since June 03, 2022. He has also served as managing partner at Axon Ventures since March 2014. Mr. Spaventa is also a founder of Truvian Sciences, a company created in 2015. He is a member of the board of the non-profit San Diego Venture Group. Previously, from 2009 to 2013, Mr. Spaventa was a co-founder of ecoATM, which was acquired by Outerwall (Coinstar) in 2012. From 2013 to 2016, Mr. Spaventa was a consultant for Edico Genome, which was acquired by Illumina in 2018. Mr. Spaventa received a B.A. in political science and international relations from the University of California, San Diego and attended law school at the University of San Diego for one year. Mr. Spaventa also holds an M.B.A. from University of California, San Diego Rady School of Management.

公司职务